Showing results (681-690 of 718) with videos related to

Sort By:
Pageof 72
Journal of Medical Genetics|January 26, 2021
DDX58(RIG-I)-related disease is associated with tissue-specific interferon pathway activationLev Prasov, Brenda L Bohnsack, Antonette S El Husny, et al.
Nature Immunology|July 22, 2020
STEEP mediates STING ER exit and activation of signalingBao-Cun Zhang, Ramya Nandakumar, Line S Reinert, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal modelAnh P Truong, Gergley Tóth, Gary D Probst, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
STING-STAT3-SOX18 Axis Drives EndMT and Epigenetic Reprogramming in SAVI Lung FibrosisDan Yang, Guibin Chen, Sachin Gaurav, et al.
Journal of Neuromuscular Diseases|September 12, 2025
Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling studyBenedikt Becker, Isabell Cordts, Jutta Becker, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2011
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegenerationSimeon Bowers, Anh P Truong, R Jeffrey Neitz, et al.
Annals of the Rheumatic Diseases|January 28, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Nature Communications|August 31, 2018
Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogrammingDavid Olagnier, Aske M Brandtoft, Camilla Gunderstofte, et al.
Frontiers in Microbiology|October 26, 2018
A Model for Trans-Kingdom Pathogenicity in Fonsecaea Agents of Human ChromoblastomycosisGheniffer Fornari, Renata Rodrigues Gomes, Juliana Degenhardt-Goldbach, et al.
Pageof 72